Integrated IMMUnoprofiling of large adaptive CANcer patients cohorts

Project: Research

Project Details

AcronymIMMUcan
StatusFinished
Effective start/end date1/03/201931/08/2024

Collaborative partners

  • King's College London
  • EORTC European Organisation for Research and Treatment of Cancer (lead)
  • SIB Swiss Institute of Bioinformatics
  • University Institute for Social and Preventive Medicine
  • Luxembourg Institute of Health
  • KU Leuven
  • Institut Jules Bordet
  • University of Birmingham
  • MARIE CURIE RESEARCH INSTITUTE
  • University of Zürich
  • Charité University of Medicine Berlin
  • Ctr Genom Regulat CRG UPF, Genes & Dis Program
  • Weizmann Institute of Science
  • INSERM
  • Merck KGaA
  • AbbVie Inc.
  • Bayer AG
  • Eli Lilly & Co Ltd
  • GSK GlaxoSmithKline Research & Development Ltd
  • Janssen Research
  • Sanofi S.A.
  • Servier
  • Pierre Fabre

Funding

  • EC European Commission: £14,977,200.00